SARA WEST: Open Payments
NPI 1639382062 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,644 in 106 payments from 13 companies in 2025. Trend: 2023 $2,019 · 2024 $1,662 · 2025 $1,644
Food & beverage: $1,644
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 21 | $259 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $259 |
| Janssen Pharmaceuticals, Inc | 13 | $237 |
| Lundbeck LLC | 15 | $220 |
| Neurocrine BioSciences, Inc. | 10 | $176 |
| Alkermes, Inc. | 10 | $164 |
| Otsuka America Pharmaceutical, Inc. | 6 | $129 |
| Vanda Pharmaceuticals Inc. | 3 | $85 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| ABBVIE INC. | 1 | $19 |
Products named: CAPLYTA, INVEGA SUSTENNA, ABILIFY MAINTENA, INGREZZA, ARISTADA, UZEDY, FANAPT, AUSTEDO XR.
Industry payments across OH — which companies pay providers there.
